Arthur J. Tipton, PhD, Vice President, SurModics and President, Brookwood Pharmaceuticals joined Southern Research in 2004 to lead the formation of a new company based on Southern’s pharmaceutical formulations business. Brookwood Pharmaceuticals was launched in January 2005 with Dr. Tipton as President and CEO. He also directed the acquisition of Alkermes’ external polymer business which was completed in November 2004. The new company, Lakeshore Biomaterials, was established as a wholly-owned subsidiary of Brookwood.
Immediately prior to joining Southern, Dr. Tipton served as Executive Vice President at Durect Corporation, a California-based, publicly traded drug delivery company. Dr. Tipton held a variety of positions in Southern BioSystems, including Vice President and Chief Scientific Officer where he led all efforts on biodegradable technology from 1993-2001. At Southern BioSystems he invented the SABER Delivery System and led its development into multiple clinical campaigns. He was a part of the negotiating team for acquisition of Southern BioSystems by Durect. Prior to joining Southern BioSystems, Dr. Tipton was with Atrix Laboratories (now part of QLT) from 1988-1993.
During his career, his development efforts have led to the launch of four commercial products. He holds 22 US patents with numerous foreign equivalents, and has more than 60 publications, presentations and invited lectures to his credit. Dr. Tipton earned his PhD in Polymer Science and Engineering from the University of Massachusetts, Amherst. He has previously served on the Boards of the Society for Biomaterials and Southern BioSystems, and currently serves on the Boards of Brookwood Pharmaceuticals, the Biotechnology Association of Alabama, and the Controlled Release Society.
